Stocks Explorer
Stocks
Sectors
Search
Invivyd, Inc.(IVVD) News
Profile
Chart
News
Analysis
IVVD price today
by TradingView
Date
Title
Jun 22
Invivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People
‹ Prev
Page
of 3
Next ›